dry mouth with tirzepatide Does Cause Mouth? What to Know dry mouth with tirzepatide On

According to the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA), common adverse effects include: Nausea (very common, affecting more than 1 in 10 patients) Diarrhoea (very common) Vomiting (common, affecting up to 1 in 10 patients) Constipation (common) Abdominal pain (common) Dyspepsia (common) Decreased appetite (very common) Abdominal distension (common) Flatulence and eructation (common) Injection-site reactions (common) These gastrointestinal symptoms typically diminish over time as the body adjusts to the medication

During a 7-year study, researchers found that GLP-1RA drugs were not more likely to cause pancreatic cancer when compared to basal insulin in a large group of people with type 2 diabetes

Currently approved UK weight management options include semaglutide (Wegovy) and tirzepatide (Mounjaro), subject to NICE Technology Appraisal eligibility criteria

The platform offers different tiers, with the medication-focused program starting at approximately $199 per month and more thorough programs that include dedicated coaching and intensive lifestyle support costing more